Abstract Purpose of Review Obesity is related to several comorbidities such as type 2
diabetes mellitus, cardiovascular disease, heart failure, and various types of cancers. While …

The prevalence of excess body weight and the associated cancer burden have been rising
over the past several decades globally. Between 1975 and 2016, the prevalence of excess …

Obesity is a leading risk factor for progression and metastasis of many cancers,, yet can in
some cases enhance survival,–and responses to immune checkpoint blockade therapies …

Lipid droplet formation is a defining histological feature in clear-cell renal cell carcinoma
(ccRCC) but the underlying mechanisms and importance of this biological behaviour have …

Context International variations in the rates of kidney cancer (KC) are considerable. An
understanding of the risk factors for KC development is necessary to generate opportunities …

Purpose: Inflammation indexes and body mass index (BMI) are easily evaluated, predict
survival, and are potentially modifiable. We evaluated the potential association of …

Over the past decade, the treatment landscape for patients with metastatic renal cell
carcinoma (RCC) has evolved dramatically. The therapeutic options available have …

Background Renal-cell carcinoma (RCC) is one of the common malignancies in the United
States. RCC incidence and mortality have been changing for many reasons. We performed …

Background Obesity increases risk for clear-cell renal cell carcinoma (ccRCC), yet obese
patients appear to experience longer survival than nonobese patients. We examined body …